fashion -WSS

fashion

author：Wikipedia 2025-10-01 18:33:33 - browse：7988

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： NYU Langone launches private ChatGPT for its health care data

explore

WSS

CRISPR base editing slashes cholesterol levels in monkeys

Setback for rare diseases as Taysha Gene Therapies pulls back

Radiation, mainstay of cancer treatment, begins a fade

Diversity in medical illustrations gets boost from Chidiebere Ibe

AstraZeneca bets AAV gene therapy will still deliver the goods

Study points to new risk in gene therapy death of Terry Horgan

entertainment

fashion

hotspot

Alkermes shareholders re

CDC advisory panel says seniors 'may' get RSV vaccine

Activists slam private health insurers over coverage restrictions

Stop Congress from blocking public access to science

As demand for Covid shots wanes, Moderna seeks its next success

European officials brace for rough respiratory virus season

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The biotech scorecard for Q4: 16 stock

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

hotspot

Study points to new risk in gene therapy death of Terry Horgan

The stability of $0 premiums in Medicare Advantage

Neuroscience startup Neumora files for IPO

The Karikó problem: Lessons for funding basic research

Australia’s approach to dialysis celebrates life

Nobel honors Karikó and Weissman's enduring partnership

knowledge

knowledge

explore

leisure time